Glypican-3, Vascular Endothelial Growth Factor and Golgi Protein-73 for Differentiation between Liver Cirrhosis and Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) accounts for more than 80% of primary liver cancers. Moreover, in the next 10 years, more than one million patients are expected to die from liver cancer as estimated by the World Health Organization. The aim of the present study is to evaluate the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamdouh, Samah, Soliman, Amira, Khorshed, Fatma, Saber, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162624/
https://www.ncbi.nlm.nih.gov/pubmed/36853298
http://dx.doi.org/10.31557/APJCP.2023.24.2.497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162624/
https://www.ncbi.nlm.nih.gov/pubmed/36853298
http://dx.doi.org/10.31557/APJCP.2023.24.2.497

Ejemplares similares